Literature DB >> 34876494

Improving Access and Guideline Adherence in Pulmonary Care in Patients With Duchenne Muscular Dystrophy.

Jacob A Kaslow1, Jonathan H Soslow2, William B Burnette3, Frank J Raucci4, Tracy J Hills5, Michaela G Ibach5, Rita C Hebblethwaite6, Kara M Arps7, Andrew G Sokolow8.   

Abstract

BACKGROUND: Duchenne muscular dystrophy (DMD) is a devastating, progressive neuromuscular disease that results in cardiopulmonary failure and death. In 2018, the DMD Care Considerations guidelines were updated to improve the multidisciplinary approach to care and promote early respiratory management. We sought to evaluate the impact of a multidisciplinary clinic on access to pulmonary care and adherence to respiratory care guidelines.
METHODS: Utilizing retrospective data, we assessed for pulmonary care between 2016-2019 and congruence with guidelines from March 2018-February 2019. Using a standardized visit protocol, subjects were monitored for adherence to pulmonary function testing (PFT) and polysomnography (PSG) recommendations.
RESULTS: Of the 84 subjects with DMD, only 51.2% had prior pulmonary involvement, and approximately one-third were seen in the year prior to clinic onset. Only 23% of subjects with a pulmonary referral completed this visit. After clinic initiation, the average age of a subject's first pulmonary contact decreased from 11.8 y to 7.9 y (P < .001), and 45% of the 77 unique clinic subjects had no previous pulmonary encounter. Adherence to PFT guidelines increased in both ambulatory (8.7% to 86.1%) and non-ambulatory subjects (25.9% to 90.1%). Approximately 79% of subjects seen in clinic either completed or had an order for PSG in the last 12 months.
CONCLUSIONS: Development of a multispecialty clinic expanded access to pulmonary care and evaluation in subjects with DMD. Continued care in this clinic will allow a better understanding of barriers to access and the opportunity to monitor long-term pulmonary health.
Copyright © 2022 by Daedalus Enterprises.

Entities:  

Keywords:  Duchenne muscular dystrophy; lung function testing; neuromuscular disorders; polysomnography; pulmonology; spirometry

Mesh:

Year:  2021        PMID: 34876494      PMCID: PMC8984916          DOI: 10.4187/respcare.09502

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  23 in total

Review 1.  Pathophysiology of Neuromuscular Respiratory Diseases.

Authors:  Joshua O Benditt
Journal:  Clin Chest Med       Date:  2018-06       Impact factor: 2.878

Review 2.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

3.  Respiratory management strategies for Duchenne muscular dystrophy: practice variation amongst Canadian sub-specialists.

Authors:  Sherri L Katz; Douglas McKim; Lynda Hoey; Nicholas Barrowman; Tamizan Kherani; Thomas Kovesi; Ian MacLusky; Jean K Mah
Journal:  Pediatr Pulmonol       Date:  2012-03-26

4.  Prevention of pulmonary morbidity for patients with neuromuscular disease.

Authors:  A C Tzeng; J R Bach
Journal:  Chest       Date:  2000-11       Impact factor: 9.410

5.  Respiratory Care Received by Individuals With Duchenne Muscular Dystrophy From 2000 to 2011.

Authors:  Jennifer G Andrews; Aida Soim; Shree Pandya; Christina P Westfield; Emma Ciafaloni; Deborah J Fox; David J Birnkrant; Christopher M Cunniff; Daniel W Sheehan
Journal:  Respir Care       Date:  2016-08-09       Impact factor: 2.258

Review 6.  Population frequencies of inherited neuromuscular diseases--a world survey.

Authors:  A E Emery
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

7.  Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: Long-term natural history with and without glucocorticoids.

Authors:  Craig M McDonald; Heather Gordish-Dressman; Erik K Henricson; Tina Duong; Nanette C Joyce; Sanjay Jhawar; Mika Leinonen; Fengming Hsu; Anne M Connolly; Avital Cnaan; Richard T Abresch
Journal:  Neuromuscul Disord       Date:  2018-08-29       Impact factor: 4.296

Review 8.  Sleep-Disordered Breathing in Duchenne Muscular Dystrophy: An Assessment of the Literature.

Authors:  Romy Hoque
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

Review 9.  Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review.

Authors:  Anneke L Francke; Marieke C Smit; Anke J E de Veer; Patriek Mistiaen
Journal:  BMC Med Inform Decis Mak       Date:  2008-09-12       Impact factor: 2.796

Review 10.  Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options.

Authors:  Antonella LoMauro; Maria Grazia D'Angelo; Andrea Aliverti
Journal:  Ther Clin Risk Manag       Date:  2015-09-28       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.